Cancer
HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA
Product number: EP07865_1
€105.00*
Prices excl. VAT plus shipping
costs
Available, delivery time:
1-3 days
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity:
95% HPLC-MS
Caution:
For research use only. Not for use in humans.
Amount in mg
1
Description
Antigen Peptide HA-1 137-145 His139 (HLA-A*02:01) VLHDDLLEA for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays. VLHDDLLEA is a linear peptidic epitope (epitope ID136896) studied as part of Minor histocompatibility protein HA-1 from Homo sapiens (human). This epitope has been studied for immune reactivity, tested in T cell assays, B cell assays and MHC ligand assays.
TechData
| Sequence: | VLHDDLLEA |
| Gene: | ARHGAP |
| Delivery: | 1-3 days |
| C-Terminus: | OH |
| N-Terminus: | H |
| Amount: | 1 mg |
| Counterion: | TFA |
| Protein: | Rho GTPase-activating protein |
| Species: | Human |
| Allele: | HLA-A*02:01 |
| Application: | Flow Cytometry |
| Indication: | Cancer |
| Purity: | 95% HPLC-MS |